I'm in Stockholm . . .
. . . this week, launching the Swedish edition of "The Whistleblower." It's called "Sjuka Pengar" or "Sick Money," since whistleblower doesn't translate well.
The schedule is packed with television, radio and other news media interviews over three days, so a good start.
And Pfizer has finally learned how to handle the situation. Instead of writing angry letters to each radio and TV show, the way they used to do this, which created additional attention, they are now ignoring me.
The first journalist I met from Swedish Radio told me she'd called Pfizer in Sweden and they told her things are so different in the U.S. that my book doesn't impact them. She also called Pfizer in the U.S. and they told her my book was a flop in the U.S., so they couldn't care less.
The irony is, of course, that Pfizer didn't take this position until after they brought the book to Court and after I thanked them for helping me with the publicity.
And of course, Pfizer didn't mention that the book made #333 on Amazon and the entire first U.S. printing has left my publisher without any returns so far . . . oh well, at least it is nice to see that they are maturing over at Big Blue. The way they behaved initially must have had their PR advisors in tears.
By the way, this is what Stockholm looks like right now. Soooooooooooo beautiful it is almost painful.